Sphingolipidosis Panel 1 Test sale cost 2040 AED
Human Rota Virus Viral Load Quantitative Test sale cost 2040 AED Human Rota Virus Viral Load Quantitative Test Cost 2,400 د.إ Original price was: 2,400 د.إ.2,040 د.إCurrent price is: 2,040 د.إ.
Episodic Ataxia Type 1 Hotspot Test sale cost 1990 AED Episodic Ataxia Type 1 Hotspot Test Cost 2,210 د.إ Original price was: 2,210 د.إ.1,990 د.إCurrent price is: 1,990 د.إ.
Sale!

Sphingolipidosis Panel 1 Test Cost

Original price was: 2,260 د.إ.Current price is: 2,040 د.إ.

-10%

The Sphingolipidosis Panel 1 Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to detect a variety of sphingolipidoses, which are a group of inherited metabolic disorders characterized by the accumulation of sphingolipids in tissues and organs. These disorders are caused by the deficiency of specific enzymes required for the metabolism of sphingolipids, leading to severe and often progressive neurological and physical symptoms.

This panel test specifically targets the genetic mutations associated with different types of sphingolipidoses, such as Gaucher’s disease, Fabry disease, Niemann-Pick disease, and others, providing a crucial insight for accurate diagnosis and treatment planning. By analyzing the patient’s DNA, the test can identify specific genetic mutations, helping in determining the exact type of sphingolipidosis, which is essential for tailoring the appropriate treatment approach and management plan for the patient.

Priced at 2040 AED, the Sphingolipidosis Panel 1 Test at DNA Labs UAE represents an important investment in personal health for those at risk of these genetic disorders. The cost reflects the comprehensive nature of the test, covering multiple conditions within a single analysis, and the advanced technology and expertise required to accurately identify the genetic markers of these diseases. Conducted in a state-of-the-art facility by a team of specialized geneticists and clinicians, the test provides a crucial step towards the effective management and treatment of sphingolipidoses, offering hope and improved quality of life for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SPHINGOLIPIDOSIS PANEL 1 Test

Test cost: AED 2040.0

Symptoms diagnosis: Metachromatic Leucodystrophy, GM 1 Gangliosidosis, GM 2 Gangliosidosis, Gaucher Disease, Niemann-Pick Disease

Test Components:

  • Metachromatic Leucodystrophy
  • GM 1 Gangliosidosis
  • GM 2 Gangliosidosis
  • Gaucher Disease
  • Niemann-Pick Disease

Price: 2040.0 AED

Sample Condition: 10 mL (7.5 mL min.) whole blood from 3 Lavender Top (EDTA) / Green Top (Sodium Heparin) tubes. Ship refrigerated within 48hrs. DO NOT FREEZE. Clinical history must accompany sample.

Report Delivery: Sample daily by 4pm; Report within 4 days

Method: Enzyme assay

Test Type: Inborn errors of metabolism

Doctor: Pediatrician

Test Department: Genetic

Pre Test Information: Give brief clinical history.

Test Details

The Sphingolipidosis Panel 1 Test is a diagnostic test used to detect and diagnose various types of sphingolipidoses, which are a group of inherited metabolic disorders. These disorders are characterized by the accumulation of sphingolipids in various tissues and organs of the body.

The test panel includes the analysis of specific enzymes involved in the metabolism of sphingolipids, such as glucocerebrosidase, alpha-galactosidase A, beta-glucocerebrosidase, and acid sphingomyelinase. Deficiencies or abnormalities in these enzymes can indicate the presence of specific sphingolipidoses, such as Gaucher disease, Fabry disease, Niemann-Pick disease, and Tay-Sachs disease.

The Sphingolipidosis Panel 1 Test is typically performed on a blood or tissue sample. The sample is analyzed in a laboratory using various biochemical and genetic techniques to measure the activity and levels of the specific enzymes.

The results of the test can help healthcare providers confirm a diagnosis, determine the severity of the condition, and guide treatment decisions. It is important to note that the Sphingolipidosis Panel 1 Test is a screening tool and may not provide a definitive diagnosis. Further confirmatory testing, such as genetic testing or additional enzyme analysis, may be necessary to confirm the specific type of sphingolipidosis.

Overall, the Sphingolipidosis Panel 1 Test is a valuable tool in the diagnosis and management of sphingolipidoses, allowing for early detection and intervention to improve patient outcomes.

Test Name SPHINGOLIPIDOSIS PANEL 1 Test
Components *MetachromaticLeucodystrophy*GM 1 Gangliosidosis*GM 2 Gangliosidosis*Gaucher Disease*NiemannPickDisease
Price 2040.0 AED
Sample Condition 10 mL (7.5 mL min.) whole blood from 3LavenderTop(EDTA)\/GreenTop (SodiumHeparin)tubes.Ship refrigeratedwithin48hrs.DONOT FREEZE. Clinical history must accompanysample.
Report Delivery SampleDailyby4pm;Report4days
Method Enzyme assay
Test type Inborn errors of metabolism
Doctor Pediatrician
Test Department: GENETIC
Pre Test Information Give brief clinical history.
Test Details

The Sphingolipidosis Panel 1 Test is a diagnostic test used to detect and diagnose various types of sphingolipidoses, which are a group of inherited metabolic disorders. These disorders are characterized by the accumulation of sphingolipids in various tissues and organs of the body.

The test panel includes the analysis of specific enzymes involved in the metabolism of sphingolipids, such as glucocerebrosidase, alpha-galactosidase A, beta-glucocerebrosidase, and acid sphingomyelinase. Deficiencies or abnormalities in these enzymes can indicate the presence of specific sphingolipidoses, such as Gaucher disease, Fabry disease, Niemann-Pick disease, and Tay-Sachs disease.

The Sphingolipidosis Panel 1 Test is typically performed on a blood or tissue sample. The sample is analyzed in a laboratory using various biochemical and genetic techniques to measure the activity and levels of the specific enzymes. The results of the test can help healthcare providers confirm a diagnosis, determine the severity of the condition, and guide treatment decisions.

It is important to note that the Sphingolipidosis Panel 1 Test is a screening tool and may not provide a definitive diagnosis. Further confirmatory testing, such as genetic testing or additional enzyme analysis, may be necessary to confirm the specific type of sphingolipidosis.

Overall, the Sphingolipidosis Panel 1 Test is a valuable tool in the diagnosis and management of sphingolipidoses, allowing for early detection and intervention to improve patient outcomes.

SKU: TEST-5044